These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15027888)

  • 1. Controversies in the follow-up and management of well-differentiated thyroid cancer.
    Ringel MD; Ladenson PW
    Endocr Relat Cancer; 2004 Mar; 11(1):97-116. PubMed ID: 15027888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
    Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
    Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of differentiated thyroid carcinoma.
    Cox AE; LeBeau SO
    Radiol Clin North Am; 2011 May; 49(3):453-62, vi. PubMed ID: 21569904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of differentiated thyroid carcinoma with radioiodine and recombinant human TSH.
    Sugino K; Ito K; Takami H
    Endocr J; 2006 Dec; 53(6):723-8. PubMed ID: 16960401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on recent developments in the therapy of differentiated thyroid cancer.
    Middendorp M; Grünwald F
    Semin Nucl Med; 2010 Mar; 40(2):145-52. PubMed ID: 20113682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions.
    Mazzaferri EL; Kloos RT
    Thyroid; 2000 Sep; 10(9):767-78. PubMed ID: 11041454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant thyroid-stimulating hormone in differentiated thyroid cancer.
    Krausz Y; Uziely B; Nesher R; Chisin R; Glaser B
    Isr Med Assoc J; 2001 Nov; 3(11):843-9. PubMed ID: 11729583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative management of differentiated thyroid cancer.
    Sabet A; Kim M
    Otolaryngol Clin North Am; 2010 Apr; 43(2):329-51, viii-ix. PubMed ID: 20510717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differentiated thyroid cancer -- 2009].
    Konrády A
    Orv Hetil; 2011 Jan; 152(5):163-70. PubMed ID: 21247857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
    Schlumberger M; Catargi B; Borget I; Deandreis D; Zerdoud S; Bridji B; Bardet S; Leenhardt L; Bastie D; Schvartz C; Vera P; Morel O; Benisvy D; Bournaud C; Bonichon F; Dejax C; Toubert ME; Leboulleux S; Ricard M; Benhamou E;
    N Engl J Med; 2012 May; 366(18):1663-73. PubMed ID: 22551127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience.
    Perros P
    J Endocrinol Invest; 1999; 22(11 Suppl):30-4. PubMed ID: 10727003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected Controversies of Radioiodine Imaging and Therapy in Differentiated Thyroid Cancer.
    Van Nostrand D
    Endocrinol Metab Clin North Am; 2017 Sep; 46(3):783-793. PubMed ID: 28760238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer.
    Kim YI; Im HJ; Paeng JC; Cheon GJ; Kang KW; Lee DS; Joon Park D; Park YJ; Chung JK
    Ann Nucl Med; 2015 Feb; 29(2):184-9. PubMed ID: 25404419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Cancer in Pediatrics.
    Machac J
    Endocrinol Metab Clin North Am; 2016 Jun; 45(2):359-404. PubMed ID: 27241970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing concepts in the management of differentiated thyroid cancer.
    Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM
    Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.